Literature DB >> 19952899

Progressive optic neuropathy in idiopathic intracranial hypertension after optic nerve sheath fenestration.

Byron N Wilkes1, R Michael Siatkowski.   

Abstract

A 16-year-old woman complaining of headache and declining vision in both eyes had papilledema, normal brain imaging, and a lumbar puncture showing a moderately high opening pressure (35 cm H2O) and normal cerebrospinal fluid constituents. For a diagnosis of idiopathic intracranial hypertension (IIH), she was treated with acetazolamide and methylprednisolone, but vision worsened, so she underwent bilateral optic sheath fenestration (ONSF). Within the 1st postoperative week, vision had improved and papilledema was less prominent. However, by the 14th postoperative day, vision had worsened and headache persisted. Lumbar puncture showed a very high opening pressure (65 cm H2O), so she underwent ventriculoperitoneal shunting. Although there was a slight initial improvement in vision, it eventually declined further. This case emphasizes that ONSF may yield initial improvement in vision and reduction in papilledema yet not prevent eventual visual loss in IIH. Whether the visual loss in this patient resulted from persistently elevated intracranial pressure after ONSF or was prefigured before ONSF occurred is unresolved. It is a reminder that patients with IIH must be monitored carefully after ONSF. If there is a suggestion of further visual loss, shunting should be considered if intracranial pressure is high.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19952899     DOI: 10.1097/WNO.0b013e3181c2530b

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  9 in total

1.  [Pseudotumor cerebri syndrome].

Authors:  K Rüther
Journal:  Ophthalmologe       Date:  2014-04       Impact factor: 1.059

Review 2.  Outcomes of endoscopic optic nerve decompression in patients with idiopathic intracranial hypertension.

Authors:  Luisam Tarrats; Gabriel Hernández; José M Busquets; Juan C Portela; Luis A Serrano; Lorena González-Sepúlveda; José R Sánchez-Pérez
Journal:  Int Forum Allergy Rhinol       Date:  2017-04-06       Impact factor: 3.858

Review 3.  An update on idiopathic intracranial hypertension.

Authors:  Matthew J Thurtell; Beau B Bruce; Nancy J Newman; Valérie Biousse
Journal:  Rev Neurol Dis       Date:  2010 Spring-Summer

Review 4.  Update on the surgical management of idiopathic intracranial hypertension.

Authors:  Nisha Mukherjee; M Tariq Bhatti
Journal:  Curr Neurol Neurosci Rep       Date:  2014-03       Impact factor: 5.081

5.  Idiopathic intracranial hypertension (pseudotumor cerebri): recognition, treatment, and ongoing management.

Authors:  Matthew J Thurtell; Michael Wall
Journal:  Curr Treat Options Neurol       Date:  2013-02       Impact factor: 3.598

Review 6.  Controversies: Optic nerve sheath fenestration versus shunt placement for the treatment of idiopathic intracranial hypertension.

Authors:  Arielle Spitze; Peter Lam; Nagham Al-Zubidi; Sushma Yalamanchili; Andrew G Lee
Journal:  Indian J Ophthalmol       Date:  2014-10       Impact factor: 1.848

7.  Elevated perioptic lipocalin-type prostaglandin D synthase concentration in patients with idiopathic intracranial hypertension.

Authors:  Achmed Pircher; Margherita Montali; Jatta Berberat; Andreas Huber; Neil R Miller; Thomas H Mader; C Robert Gibson; Albert Neutzner; Luca Remonda; Hanspeter E Killer
Journal:  Brain Commun       Date:  2022-09-26

Review 8.  Idiopathic intracranial hypertension; research progress and emerging themes.

Authors:  Ruchika Batra; Alexandra Sinclair
Journal:  J Neurol       Date:  2013-10-02       Impact factor: 4.849

9.  Perioptic Cerebrospinal Fluid Dynamics in Idiopathic Intracranial Hypertension.

Authors:  Achmed Pircher; Margherita Montali; Joachim Pircher; Jatta Berberat; Luca Remonda; Hanspeter E Killer
Journal:  Front Neurol       Date:  2018-06-28       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.